Atıf Formatları
Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Oner Et Al. , "Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase," LEUKEMIA & LYMPHOMA , vol.33, pp.361-364, 1999

Oner, A. Et Al. 1999. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase. LEUKEMIA & LYMPHOMA , vol.33 , 361-364.

Oner, A., Gurgey, A., Kirazli, S., Okur, H., & Tunc, B., (1999). Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase. LEUKEMIA & LYMPHOMA , vol.33, 361-364.

Oner, AF Et Al. "Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase," LEUKEMIA & LYMPHOMA , vol.33, 361-364, 1999

Oner, AF Et Al. "Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase." LEUKEMIA & LYMPHOMA , vol.33, pp.361-364, 1999

Oner, A. Et Al. (1999) . "Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase." LEUKEMIA & LYMPHOMA , vol.33, pp.361-364.

@article{article, author={AF Oner Et Al. }, title={Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase}, journal={LEUKEMIA & LYMPHOMA}, year=1999, pages={361-364} }